Fig. 2: Differences in major cell types compositions across disease conditions.
From: Single-cell immune profiling reveals distinct immune response in asymptomatic COVID-19 patients
a Proportion of cell types in PBMCs of healthy controls (HCs, n = 3), moderate (n = 8), severe (n = 1), and asymptomatic patients (n = 7). Colored according to cell type information. b Boxplots showing the percentages of each cell type to total cell number per PBMC sample in four disease conditions (HCs, asymptomatic, moderate, and severe) and stages. Boxes are colored according to disease conditions and stages of the moderate condition. The PBMC samples from moderate patients were classified into 3 stages (<10 days, 10–20 days, and >20 days) based on the days after symptom onset. Boxplots indicate the median and interquartile range (IQR); the whiskers represent 1.5 times the IQR. Each circle represents the proportion of each PBMC sample. Two-sided Kruskal–Wallis test was used for analysis, and a p value < 0.05 is considered significant. *p < 0.05, **p < 0.01, ***p < 0.001. No asterisk indicates no statistical significance
